We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
Cap. Flow
+$552M
Cap. Flow %
5.91%
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$39.4M
3
INTC icon
Intel
INTC
+$29.2M
4
QCOM icon
Qualcomm
QCOM
+$27.6M
5
DHR icon
Danaher
DHR
+$26M

Top Sells

Rank Stock Value
1
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$49.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$41.6M
3
ARQL
Arqule Inc
ARQL
+$26.5M
4
ARWR icon
Arrowhead Research
ARWR
+$24.9M
5
MRK icon
Merck
MRK
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 19.55%
3 Financials 10.18%
4 Consumer Discretionary 9.32%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNY
176
Bank of New York Mellon
BNY
$108B
$12.4M 0.13%
246,816
+151,606
+159% +$7.24M
DAL icon
177
Delta Air Lines
DAL
$55.9B
$12.4M 0.13%
211,686
+24,571
+13% +$1.38M
HIG icon
178
Hartford Financial Services
HIG
$38.5B
$12.4M 0.13%
203,568
+11,566
+6% +$694K
LULU icon
179
lululemon athletica
LULU
$13B
$12.4M 0.13%
53,350
-1,136
-2% -$242K
CAT icon
180
Caterpillar
CAT
$409B
$12.3M 0.13%
83,157
+321
+0.4% +$44.8K
CVX icon
181
Chevron
CVX
$388B
$12.2M 0.13%
101,607
+8,010
+9% +$943K
TENB icon
182
Tenable Holdings
TENB
$3.56B
$12.1M 0.13%
505,863
+23,984
+5% +$584K
APLS
183
DELISTED
Apellis Pharmaceuticals
APLS
$12M 0.13%
392,200
-42,500
-10% -$1.18M
ES icon
184
Eversource Energy
ES
$28.2B
$11.9M 0.13%
139,682
-6,239
-4% -$519K
SYK icon
185
Stryker
SYK
$127B
$11.8M 0.13%
56,299
-1,104
-2% -$229K
AMT icon
186
American Tower
AMT
$77.7B
$11.7M 0.13%
51,018
-9,588
-16% -$2.09M
PDD icon
187
Pinduoduo
PDD
$118B
$11.7M 0.13%
308,600
-40,400
-12% -$1.51M
COST icon
188
Costco
COST
$415B
$11.6M 0.12%
39,608
-134
-0.3% -$39.8K
EXEL icon
189
Exelixis
EXEL
$13.9B
$11.6M 0.12%
658,471
-23,871
-3% -$405K
AMP icon
190
Ameriprise Financial
AMP
$46.8B
$11.5M 0.12%
69,159
+6,508
+10% +$1.01M
TGT icon
191
Target
TGT
$62.1B
$11.5M 0.12%
89,522
-1,776
-2% -$208K
BBY icon
192
Best Buy
BBY
$18B
$11.4M 0.12%
130,001
-6,258
-5% -$479K
IMMU
193
DELISTED
Immunomedics Inc
IMMU
$11.4M 0.12%
537,037
+47,737
+10% +$842K
PRU icon
194
Prudential Financial
PRU
$41.7B
$11.3M 0.12%
+120,833
New +$11.1M
HPE icon
195
Hewlett Packard
HPE
$63.2B
$11.3M 0.12%
188,477
-27,235
-13% -$435K
ARVN icon
196
Arvinas
ARVN
$518M
$11.2M 0.12%
272,806
+27,015
+11% +$791K
CETV
197
DELISTED
Central European Media Enterprises Ltd
CETV
$11.2M 0.12%
+2,468,001
New +$11.1M
CY
198
DELISTED
Cypress Semiconductor
CY
$11.2M 0.12%
478,236
+326,167
+214% +$7.63M
CDW icon
199
CDW
CDW
$17.1B
$11M 0.12%
77,300
+4,176
+6% +$553K
ECL icon
200
Ecolab
ECL
$75.6B
$10.9M 0.12%
56,364
+26,583
+89% +$5.05M
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2019 Portfolio in Review

As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.

  • Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
  • Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
  • Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
  • Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
  • Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
  • Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.

Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.